global nano medicince market

Global Nano Medicine Market
The Global Nanomedicine Market was worth USD 125.3 billion in 2017 and is projected
to grow at a CAGR of 12.8%, to reach USD 228.8 billion by 2022. The application of
various techniques and instruments of nanotechnology in the field of medicine is known
as Nanomedicine. It involves using nanoscale materials to diagnose diseases, drug
delivery and other functions. Nanomedicine has the potential to revolutionize medicine in
the future.
One of the major challenges for the use of nanoparticles in medicine is to make the
materials as biocompatible. Applications of nanocapsules in drug delivery have shown
excellent results in chemotherapy. Nanomedicine enables great precision in both
diagnostics and therapeutics which is not possible before. Pipeline products which are
being developed with the intention to target cancerous tumors are expected to boost the
nanomedicine market.
Increasing applications of nanomaterials such as nanocapsules and nanotubes in drug
delivery systems, growing number of cancer and cardiovascular diseases, increasing
public and private investments on research activities in nanomedicine and
advancements in the biodegradable nanoparticles are the major factors propelling the
growth of nanomedicine market. However, unfavorable approval processes possibility for
unintended risks during therapies and high cost of treatment using nanomedicine are
hindering the market growth.
The Nanomedicine market is segmented by product, disease type, nanomolecule type
and region. On the basis of product, the market is categorized into Diagnostic Imaging,
Regenerative Medicine, Drug Delivery, Implants, Vaccines and Others. Drug delivery
products are accounted for the largest market share. It is due to the incredible precision
with which drugs are delivered to the target cells or tissues in the body. On the basis of
disease type, the market is categorized into Cardiovascular Diseases, Neurological
Diseases, Ophthalmological Diseases, Infectious Diseases, Immunological Diseases,
Orthopedic Disorders, Oncological Diseases and Others. Oncological diseases segment
dominates the market. It is because majority of the research conducted on
nanomedicine is focused on developing products for cancer treatment. Cardiovascular
diseases segment is expected to be rapidly growing owing to the increase in the geriatric
population. On the basis of nanomolecule type, the market is categorized into
Nanotubes, Nanoparticles, Nanodevices, Nanoshells and Others.
On the basis of region, the global Nanomedicine market is segmented into North
America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America
leads the Nanomedicine market due to the huge investments on research in
nanomedicine from government organizations in Unites States. Asia Pacific is expected
to be the fastest growing market due to the high incidences of cancer and cardiovascular
diseases owing to large geriatric population.
Some of the major players in Nanomedicine market are Johnson & Johnson, Merck &
Co, Pfizer, Abbott Laboratories, GE Healthcare, Celgene Corporation, Nanosphere, Inc,
Gilead Sciences, Hoffmann-La Roche, Nanospectra Biosciences, and Arrowhead
Pharmaceuticals.
TABLE OF CONTENTS
1. Introduction
+1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com